MEIP - MEI Pharma - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

MEIP is currently covered by 5 analysts with an average price target of $23.62. This is a potential upside of $20.42 (638.13%) from yesterday's end of day stock price of $3.2.

MEI Pharma's activity chart (see below) currently has 7 price targets and 20 ratings on display. The stock rating distribution of MEIP is 37.5% BUY, 25% SELL and 37.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 11.11% with an average time for these price targets to be met of 72 days.

Highest price target for MEIP is $7, Lowest price target is $7, average price target is $23.62.

Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 14-Feb-2024.

Currently out of the existing stock ratings of MEIP, 3 are a BUY (37.5%), 2 are a SELL (25%), 3 are a HOLD (37.5%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

7

$3.17 (82.77%)

9

2 months 4 days ago

0/3 (0%)

$2.29 (48.62%)

Sell

2

$-1.83 (-47.78%)

20

1 years 2 months 10 days ago

0/3 (0%)

$-3.36 (-62.69%)

Buy

1 years 4 months 12 days ago

2/2 (100%)

$-42.22 (-77.87%)

648

Buy

6

1 years 10 months 12 days ago

0/1 (0%)

$1.82 (43.54%)

Hold

2

$-1.54 (-43.50%)

80

2 years 24 days ago

0/2 (0%)

$-7.8 (-79.59%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MEIP (MEI Pharma) average time for price targets to be met?

On average it took 72 days on average for the stock forecasts to be realized with a an average price target met ratio 11.11

Which analyst has the current highest performing score on MEIP (MEI Pharma) with a proven track record?

ROBYN KARNAUSKAS

Which analyst has the current lower performing score on MEIP (MEI Pharma) with a proven track record?

JUSTIN ZELIN

Which analyst has the most public recommendations on MEIP (MEI Pharma)?

Robyn Karnauskas works at TRUIST and has 27 price targets and 16 ratings on MEIP

Which analyst is the currently most bullish on MEIP (MEI Pharma)?

Thomas Shrader with highest potential upside - $172.99

Which analyst is the currently most reserved on MEIP (MEI Pharma)?

Chris Howerton with lowest potential downside - -$1.83

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?